EXHIBIT 10.1
THIRD AMENDMENT OF
STOCK PURCHASE AGREEMENT
THIS AMENDMENT is made as of January 31, 2001 by and among Medi-Ject
Corporation. a Minnesota corporation, ("Medi-Ject"); Permatec Holding AG, a
company organized under the laws of Switzerland ("Permatec"); Permatec Pharma
AG, a company organized under the laws of Switzerland ("Pharma"); Permatec
Technologie AG, a company organized under the laws of Switzerland
("Technologie"): and Permatec NV, a company organized under the laws of the
Netherlands Antilles ("NV") (Pharma, Technologie and NV sometimes being referred
to herein collectively as the "Subsidiaries" and individually as "Subsidiary").
WITNESSETH:
WHEREAS, Medi-Ject, Permatec and the Subsidiaries have entered into that
certain Stock Purchase Agreement dated July 14, 2000 (as amended, the "Stock
Purchase Agreement");
WHEREAS, Medi-Ject, Permatec and the Subsidiaries desire to amend the Stock
Purchase Agreement as provided herein; and
NOW, THEREFORE, in consideration of the premises and their mutual covenants
and agreements contained herein, and for other good and valuable consideration,
the receipt and sufficiency of which is hereby acknowledged, the parties hereto
agree as follows:
1. Amendment of Permatec Disclosure Schedule. Notwithstanding anything to
-----------------------------------------
the contrary contained in the Stock Purchase Agreement, for purposes of
determining the accuracy and completeness of the representations and warranties
of Permatec and the Subsidiaries contained in the Stock Purchase Agreement as of
the Closing Date, the term "Permatec Disclosure Schedule" shall mean the
Permatec Disclosure Schedule contained in the Stock Purchase Agreement, as
modified by the Supplement to Permatec Disclosure Schedule dated January 31,
2001 and attached hereto as Exhibit A.
1. Amendment of Medi-Ject Disclosure Schedule. Notwithstanding anything
------------------------------------------
to the contrary contained in the Stock Purchase Agreement, for purposes of
determining the accuracy and completeness of the representations and warranties
of Medi-Ject contained in the Stock Purchase Agreement as of the Closing Date,
the term "Medi-Ject Disclosure Schedule" shall mean the Medi-Ject Disclosure
Schedule contained in the Stock Purchase Agreement, as modified by the
Supplement to Medi-Ject Disclosure Schedule dated January 31, 2001 and attached
hereto as Exhibit B.
2. Continuing Effect. The Stock Purchase Agreement, except as amended
-----------------
hereby, shall be and remain in full force and effect.
1
IN WITNESS WHEREOF, this Amendment has been executed as of the day and year
first above written.
MEDI-JECT CORPORATION
By: /s/ Franklin Pass
-----------------
Name: Franklin Pass
Title: Chairman and Chief Executive
Officer
PERMATEC HOLDING AG
By: /s/ Xxxxxxx Xxxxxxx
-------------------
Name: Xx. Xxxxxxx Xxxxxxx
Title: Chairman of the Group
PERMATEC PHARMA AG
By: /s/ Xxxxxxx Xxxxxxx
-------------------
Name: Xx. Xxxxxxx Xxxxxxx
Title: Chairman of the Group
PERMATEC TECHNOLOGIE AG
By: /s/ Xxxxxxx Xxxxxxx
-------------------
Name: Xx. Xxxxxxx Xxxxxxx
Title: Chairman of the Group
PERMATEC NV
By: /s/ Xxxxxxx Xxxxxxx
-------------------
Name: Xx. Xxxxxxx Xxxxxxx
Title: Chairman of the Group
2
